Introduction
Bariticinib Real World Evidence
Objectives
"- Reinforce Benefit risk/profile of Olumiant using RWE & long-term data
- To present the most updated results on Baricitinib efficacy and safety for the management of patients with Rheumatoid Arthritis"
This Course For :
Physician
( Family Medicine , Internal Medicine , Rheumatology , General practitioner )
Resident / Fellow
( Family Medicine , Internal Medicine , Rheumatology , General practitioner )
Speaker
Rieke Alten
Professor of Medicine and Head of the Department of Internal Medicine, Rheumatology, Clinical Immunology, Osteology at Schlosspark-Klinik, University Medicine Berlin, where she also serves as the Director of the Rheumatology Research Center
Peter C. Taylor
Trained at Cambridge and Oxford Universities and gained a PhD from the University of London. He holds the Norman Collisson chair of musculoskeletal sciences at Oxford University where he is the Director of Clinical Sciences
Provided by :
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
21 Mar 2023 To 21 Mar 2023 -
07:00 PM To 08:00 PM 
Certificate Available 
Online Click Here
- 292
Add to Calendar
03/21/2023 07:00 PM
03/21/2023 08:00 PM
Asia/ Riyadh
Baricitinib in the Management of RA: From Clinical Evidence to Real World Experience
Baricitinib in the Management of RA: From Clinical Evidence to Real World Experience
https://medicalacademy.org/portal/event/view/1941
